FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Howard Shulman

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
H Joachim Deeg; Min Fang; Frederick R Appelbaum; Boglarka Gyurkocza; David Myerson; John M Pagel; Uwe Platzbecker; Jerald P Radich; Aravind Ramakrishnan; Brenda M Sandmaier; Bart L Scott; Howard M Shulman; Mohamed L Sorror; Derek L Stirewalt; Rainer Storb; Wendy A Wilson; Ted Gooley
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
H Joachim Deeg; Emily Spaulding; Howard M Shulman
Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.
M Sakai; S I Strasser; Howard M Shulman; S J McDonald; H Gary Schoch; George B McDonald
Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Howard Shulman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: H Joachim Deeg; Min Fang; Frederick R Appelbaum; Boglarka Gyurkocza; David Myerson; John M Pagel; Uwe Platzbecker; Jerald P Radich; Aravind Ramakrishnan; Brenda M Sandmaier; Bart L Scott; Howard M Shulman; Mohamed L Sorror; Derek L Stirewalt; Rainer Storb; Wendy A Wilson; Ted Gooley
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
Blood 2012;120(7):1398-408.
2009: H Joachim Deeg; Emily Spaulding; Howard M Shulman
Iron overload, hematopoietic cell transplantation, and graft-versus-host disease.
Leukemia & lymphoma 2009;50(10):1566-72.
2009: M Sakai; S I Strasser; Howard M Shulman; S J McDonald; H Gary Schoch; George B McDonald
Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome.
Bone marrow transplantation 2009;44(7):441-7.
2009: Steven Bair; Emily Spaulding; Jaakko Parkkinen; Howard M Shulman; Vladimir Lesnikov; Mary Beauchamp; François Canonne-Hergaux; Kris V Kowdley; H Joachim Deeg
Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.
Blood 2009;113(8):1841-4.
2009: Jo Nadine Fleming; Howard M Shulman; Richard A Nash; Pamela Y Johnson; Thomas N Wight; Allen Gown; Stephen M Schwartz
Cutaneous chronic graft-versus-host disease does not have the abnormal endothelial phenotype or vascular rarefaction characteristic of systemic sclerosis.
PloS one 2009;4(7):e6203.
2008: Vladimir Lesnikov; Nicholas Gorden; Nelson Fausto; Emily Spaulding; Jean Campbell; Howard M Shulman; Robert E Fleming; H Joachim Deeg
Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2.
Apoptosis : an international journal on programmed cell death 2008;13(8):1005-12.
2008: Jo N Fleming; Richard A Nash; D O McLeod; David F Fiorentino; Howard M Shulman; M Kari Connolly; Jerry A Molitor; Gretchen Henstorf; Robert Lafyatis; David K Pritchard; Lawrence D Adams; Daniel E Furst; Stephen M Schwartz
Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?
PloS one 2008;3(1):e1452.
2007: Chunkang Chang; Barry E Storer; Bart L Scott; Eileen Bryant; Howard M Shulman; Mary E D Flowers; Brenda M Sandmaier; Robert P Witherspoon; Richard A Nash; Jean E Sanders; Antonio Bedalov; John A Hansen; Bruce E Clurman; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
Blood 2007;110(4):1379-87.
2007: Richard A Nash; Peter A McSweeney; Leslie J Crofford; Muneer H Abidi; Chien-Shing Chen; J David Godwin; Theodore A Gooley; Leona A Holmberg; Gretchen Henstorf; Charles F LeMaistre; Maureen D Mayes; Kevin T McDonagh; Bernadette McLaughlin; Jerry A Molitor; J Lee Nelson; Howard M Shulman; Rainer Storb; Federico Viganego; Mark H Wener; James R Seibold; Keith M Sullivan; Daniel E Furst
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
Blood 2007;110(4):1388-96.
2006: Richard A Nash; Peter A McSweeney; J Lee Nelson; Mark H Wener; George E Georges; Amelia A Langston; Howard M Shulman; Keith M Sullivan; Julie Lee; Gretchen Henstorf; Rainer Storb; Daniel E Furst
Allogeneic marrow transplantation in patients with severe systemic sclerosis: resolution of dermal fibrosis.
Arthritis and rheumatism 2006;54(6):1982-6.
2006: Kirk R Schultz; David B Miklos; Daniel Fowler; Ken Cooke; Judith A Shizuru; Emmanuel Zorn; Ernst Holler; James L M Ferrara; Howard M Shulman; Stephanie J Lee; Paul Martin; Alexandra H Filipovich; Mary E D Flowers; Daniel Weisdorf; Daniel Couriel; Peter A Lachenbruch; Barbara Mittleman; Georgia B Vogelsang; Steven Z Pavletic
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):126-37.
2006: Howard M Shulman; David Kleiner; Stephanie J Lee; Thomas Morton; Steven Z Pavletic; Evan Farmer; JEAN MORESI; Joel K Greenson; Anne Janin; Paul J Martin; George McDonald; Mary E D Flowers; Maria Turner; Jane Atkinson; Jay H Lefkowitch; M Kay Washington; Victor G Prieto; Stella K Kim; Zsolt B Argenyi; A Hafeez Diwan; Asif Rashid; Kim Hiatt; Daniel Couriel; Kirk R Schultz; Sharon Hymes; Georgia B Vogelsang
Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1):31-47.
2005: Alexandra H Filipovich; Daniel Weisdorf; Steven Z Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia A Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk R Schultz; Howard M Shulman; Maria Turner; Georgia B Vogelsang; Mary E D Flowers
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):945-56.
2004: Vladimir Lesnikov; Marina Lesnikova; Howard M Shulman; Heather-Marie Wilson; David M Hockenbery; Markus Kocher; Walter Pierpaoli; H Joachim Deeg
Prevention of Fas-mediated hepatic failure by transferrin.
Laboratory investigation; a journal of technical methods and pathology 2004;84(3):342-52.
2004: William J Hogan; Michael B Maris; Barry Storer; Brenda M Sandmaier; David G Maloney; H Gary Schoch; Ann Woolfrey; Howard M Shulman; Rainer Storb; George B McDonald
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.
Blood 2004;103(1):78-84.
2002: H Joachim Deeg; Barry Storer; John T Slattery; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Paul J Martin; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Howard M Shulman; Edus H Warren; Robert P Witherspoon; Eileen Bryant; Thomas R Chauncey; Lisa Getzendaner; Rainer Storb; Frederick R Appelbaum
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Pankaj Rajvanshi; Howard M Shulman; Eric L Sievers; George B McDonald
Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy.
Blood 2002;99(7):2310-4.
2002: Laurie D DeLeve; Howard M Shulman; George B McDonald
Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).
Seminars in liver disease 2002;22(1):27-42.
2002: Richard A Nash; Alessandra Takatu; Ziding Feng; Sherrill Slichter; Kraig Abrams; German Espino; M John Gass; George E Georges; Peter A McSweeney; Howard M Shulman; Rainer Storb
Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):360-7.
2000: S I Strasser; Howard M Shulman; M E Flowers; R Reddy; D A Margolis; M Prumbaum; S E Seropian; George B McDonald
Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
Hepatology (Baltimore, Md.) 2000;32(6):1265-71.
2000: Michael D Saunders; Howard M Shulman; C S Murakami; T R Chauncey; W I Bensinger; George B McDonald
Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation.
The American journal of surgical pathology 2000;24(7):1004-8.
2000: J Yu; Wendy Leisenring; W Fritschle; Shelly Heimfeld; Howard M Shulman; William I Bensinger; Leona A Holmberg; Scott D Rowley
Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection.
Bone marrow transplantation 2000;25(11):1157-64.
2000: H Joachim Deeg; C Beckham; Michael R Loken; Eileen Bryant; Marina Lesnikova; Howard M Shulman; Ted Gooley
Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome.
Leukemia & lymphoma 2000;37(3-4):405-14.
2000: H Joachim Deeg; Howard M Shulman; Jeanne E Anderson; Eileen Bryant; Theodore A Gooley; John T Slattery; Claudio Anasetti; Alexander Fefer; Rainer Storb; Frederick R Appelbaum
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
Blood 2000;95(4):1188-94.
2000: Richard A Nash; R Kurzrock; John DiPersio; Julie M Vose; Charles Linker; D Maharaj; Auayporn Nademanee; R Negrin; Stephen D Nimer; Howard M Shulman; Mark Ashby; Denny Jones; Frederick R Appelbaum; Richard Champlin
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):25-34.
1999: Howard M Shulman; D Wells; T Gooley; David Myerson; Eileen Bryant; Michael R Loken
The biologic significance of rare peripheral blasts after hematopoietic cell transplantation is predicted by multidimensional flow cytometry.
American journal of clinical pathology 1999;112(4):513-23.
1999: S I Strasser; Howard M Shulman; George B McDonald
Cholestasis after hematopoietic cell transplantation.
Clinics in liver disease 1999;3(3):651-68, x.
1999: Stefano Quaranta; Howard M Shulman; Alaa Ahmed; Yehuda Shoenfeld; J Peter; G B McDonald; Judith A van de Water; Ross Coppel; Cecilia Ostlund; Howard J Worman; Mario Rizzetto; Koichi tsuneyama; Yasuni Nakanuma; Aftab A Ansari; F Locatelli; S Paganin; Floriano Rosina; M Manns; M Eric Gershwin
Autoantibodies in human chronic graft-versus-host disease after hematopoietic cell transplantation.
Clinical immunology (Orlando, Fla.) 1999;91(1):106-16.
1999: H Joachim Deeg; Ulrich Schuler; Howard M Shulman; M Ehrsam; Ulf Renner; Cong Yu; Rainer Storb; Gerhard Ehninger
Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(5):316-21.
1998: Denise A Wells; M C Hall; Howard M Shulman; Michael R Loken
Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias.
Leukemia 1998;12(12):2015-23.
1998: J H van Burik; Wendy Leisenring; David Myerson; R C Hackman; Howard M Shulman; G E Sale; Raleigh A Bowden; George B McDonald
The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
Medicine 1998;77(4):246-54.
1998: Denise A Wells; George E Sale; Howard M Shulman; David Myerson; Eileen Bryant; T Gooley; Michael R Loken
Multidimensional flow cytometry of marrow can differentiate leukemic from normal lymphoblasts and myeloblasts after chemotherapy and bone marrow transplantation.
American journal of clinical pathology 1998;110(1):84-94.
1998: Rainer Storb; R Raff; H Joachim Deeg; T Graham; Frederick R Appelbaum; Friedrich Schuening; Howard M Shulman; K Seidel; Wendy Leisenring
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.
International journal of radiation oncology, biology, physics 1998;40(4):961-6.
1998: Keith M Sullivan; E Kansu; Barry Storer; J Jocom; G Emerson; T Reagan; M Vaughn Emerson; MF Siadak; C Davis; Frederick R Appelbaum; C Dean Buckner; John A Hansen; Howard M Shulman; Rainer Storb; George B McDonald
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):20-6.
1997: C W Ko; Ted Gooley; H Gary Schoch; David Myerson; Robert C Hackman; Howard M Shulman; George E Sale; Sum P Lee; George B McDonald
Acute pancreatitis in marrow transplant patients: prevalence at autopsy and risk factor analysis.
Bone marrow transplantation 1997;20(12):1081-6.
1997: Laurie D DeLeve; X Wang; N Kaplowitz; Howard M Shulman; J A Bart; A van der Hoek
Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains.
Biochemical pharmacology 1997;53(9):1339-45.
1997: Rainer Storb; Cong Yu; JL Wagner; H Joachim Deeg; Richard A Nash; Hans-Peter Kiem; Wendy Leisenring; Howard M Shulman
Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Blood 1997;89(8):3048-54.
1996: William I Bensinger; C Dean Buckner; Claudio Anasetti; Reginald Clift; Rainer Storb; T Barnett; Thomas R Chauncey; Howard M Shulman; Frederick R Appelbaum
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: J E Anderson; Frederick R Appelbaum; Gary Schoch; T Gooley; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Thomas R Chauncey; Reginald Clift; Kristine C Doney; M Flowers; John A Hansen; Paul J Martin; Dana C Matthews; Jean E Sanders; Howard M Shulman; K M Sullivan; Robert P Witherspoon; Rainer Storb
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1995: Cong Yu; Rainer Storb; B Mathey; H Joachim Deeg; Friedrich Schuening; T C Graham; K Seidel; R Burnett; JL Wagner; Howard M Shulman; Brenda M Sandmaier
DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.
Blood 1995;86(11):4376-81.
1995: Rainer Storb; R F Raff; H Joachim Deeg; T C Graham; Friedrich Schuening; Howard M Shulman; Eileen Bryant
DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment.
Transplantation 1995;59(10):1481-2.
1994: Rainer Storb; R F Raff; Frederick R Appelbaum; H Joachim Deeg; T C Graham; Friedrich Schuening; Howard M Shulman; Cong Yu; Eileen Bryant; R Burnett
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.
Blood 1994;84(10):3558-66.
1994: I Schwarzinger; R F Raff; M Flowers; Dietger Niederwieser; T Graham; Howard M Shulman; Frederick R Appelbaum; Friedrich Schuening; Rainer Storb
Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Bone marrow transplantation 1994;13(3):303-9.
1993: J E Anderson; Frederick R Appelbaum; Lloyd Fisher; Gary Schoch; Howard M Shulman; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Kristine C Doney
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
1993: Rainer Storb; R F Raff; T Graham; Frederick R Appelbaum; H J Deeg; Friedrich Schuening; Howard M Shulman; M Pepe
Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model.
International journal of radiation oncology, biology, physics 1993;26(2):275-83.
1992: R F Raff; Rainer Storb; T Graham; George E Sale; Howard M Shulman; M Pepe; H Joachim Deeg; Friedrich Schuening; Frederick R Appelbaum; J M Fidler
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
Transplantation 1992;54(5):947-8.
1991: C C Badger; J Davis; C Nourigat; Z M Wu; T E Hui; D R Fisher; Howard M Shulman; Frederick R Appelbaum; Janet F Eary; K A Krohn
Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
Cancer research 1991;51(21):5921-8.
1990: T P Loughran; K Sullivan; T Morton; C Beckham; M Schubert; Robert P Witherspoon; George E Sale; Jean Sanders; Lloyd Fisher; Howard M Shulman
Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Blood 1990;76(1):228-34.
1990: Frederick R Appelbaum; J Barrall; Rainer Storb; Lloyd Fisher; Gary Schoch; R E Ramberg; Howard M Shulman; Claudio Anasetti; Scott I Bearman; P Beatty
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
Annals of internal medicine 1990;112(8):590-7.
1988: Rainer Storb; R F Raff; Frederick R Appelbaum; Friedrich Schuening; Brenda M Sandmaier; Howard M Shulman; H Joachim Deeg; T Graham
Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Transplantation 1988;45(1):236-9.
1986: C C Badger; K A Krohn; Howard M Shulman; N Flournoy; Irwin D Bernstein
Experimental radioimmunotherapy of murine lymphoma with 131I-labeled anti-T-cell antibodies.
Cancer research 1986;46(12 Pt 1):6223-8.
1986: C C Badger; Howard M Shulman; A V Peterson; Irwin D Bernstein
Monoclonal antibody therapy of spontaneous AKR T-cell leukemia.
Cancer research 1986;46(8):4058-63.
1986: K M Sullivan; H J Deeg; Jean Sanders; A Klosterman; D Amos; Howard M Shulman; George E Sale; P Martin; Robert P Witherspoon; F Appelbaum
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.
Blood 1986;67(4):1172-5.
1985: C C Badger; K A Krohn; A V Peterson; Howard M Shulman; Irwin D Bernstein
Experimental radiotherapy of murine lymphoma with 131I-labeled anti-Thy 1.1 monoclonal antibody.
Cancer research 1985;45(4):1536-44.
1982: C Badger; C D Buckner; ED Thomas; Reginald Clift; Jean E Sanders; P S Stewart; R Storb; K M Sullivan; Howard M Shulman; N Flournoy
Allogeneic marrow transplantation for acute leukemia in relapse.
Leukemia research 1982;6(3):383-7.
1981: H J Deeg; R Storb; P L Weiden; D Schumacher; Howard M Shulman; T Graham; ED Thomas
High-dose total-body irradiation and autologous marrow reconstitution in dogs: dose-rate-related acute toxicity and fractionation-dependent long-term survival.
Radiation research 1981;88(2):385-91.